WHO-UMC IDMP Management and Publish API
0.1.0 - CI Build
WHO-UMC IDMP Management and Publish API
0.1.0 - CI Build
WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Task",
"id" : "UK-emc-00001",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Task UK-emc-00001</b></p><a name=\"UK-emc-00001\"> </a><a name=\"hcUK-emc-00001\"> </a><a name=\"UK-emc-00001-en-US\"> </a><p><b>status</b>: Draft</p><p><b>intent</b>: proposal</p><p><b>priority</b>: Routine</p><p><b>authoredOn</b>: 2024-01-17</p><p><b>lastModified</b>: 2024-01-17</p><blockquote><p><b>input</b></p><p><b>type</b>: <span title=\"Codes:{http://who-umc.org/idmp/CodeSystem/task-input-type mpd-request-resource}\">Medicinal Product for PhPID request</span></p><p><b>value</b>: <a href=\"#hcUK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72\">MedicinalProductDefinition: identifier = http://medicines.org.uk/product#511; type = Medicinal Product; domain = Human use; status = Active; statusDate = 2020-08-03 15:11:41+0000; combinedPharmaceuticalDoseForm = Tablet and powder for oral solution; classification = methotrexate</a></p></blockquote><blockquote><p><b>input</b></p><p><b>type</b>: <span title=\"Codes:{http://who-umc.org/idmp/CodeSystem/task-input-type ingredient-request-resource}\">Ingredient for PhPID request</span></p><p><b>value</b>: <a href=\"#hcUK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073\">Ingredient: status = active; role = Active</a></p></blockquote><blockquote><p><b>input</b></p><p><b>type</b>: <span title=\"Codes:{http://who-umc.org/idmp/CodeSystem/task-input-type organization-request-resource}\">Test by Datapharm for PhPID request</span></p><p><b>value</b>: <a href=\"#hcUK-emc-00001/dti\">Organization Datapharm Test Inc</a></p></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition #5d02cfc1-053f-4694-9ce8-d0ee6c658b72</b></p><a name=\"UK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72\"> </a><a name=\"hcUK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72\"> </a><a name=\"UK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72-en-US\"> </a><p><b>identifier</b>: <code>http://medicines.org.uk/product</code>/511</p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-type MedicinalProduct}\">Medicinal Product</span></p><p><b>domain</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-domain Human}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><p><b>statusDate</b>: 2020-08-03 15:11:41+0000</p><p><b>combinedPharmaceuticalDoseForm</b>: <span title=\"Codes:{http://hl7.org/fhir/combined-dose-form 100000074064}\">Tablet and powder for oral solution</span></p><p><b>classification</b>: <span title=\"Codes:{http://www.whocc.no/atc L04AX03}\">methotrexate</span></p><p><b>attachedDocument</b>: SPC/511</p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Contact</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"#hcUK-emc-00001/dti\">Organization Datapharm Test Inc</a></td></tr></table><blockquote><p><b>name</b></p><p><b>productName</b>: Methotrexate 2.5 mg Tablets</p><p><b>type</b>: <span title=\"Codes:\">RegulatorApprovedName</span></p><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{urn:iso:std:iso:3166 GBR}\">United Kingdom</span></td><td><span title=\"Codes:{urn:iso:std:iso:3166 GBR}\">United Kingdom</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 en}\">English</span></td></tr></table></blockquote></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Ingredient #54c6c580-5b34-4032-9403-c9d2154ac073</b></p><a name=\"UK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073\"> </a><a name=\"hcUK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073\"> </a><a name=\"UK-emc-00001/54c6c580-5b34-4032-9403-c9d2154ac073-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: <a href=\"#hcUK-emc-00001/5d02cfc1-053f-4694-9ce8-d0ee6c658b72\">MedicinalProductDefinition: identifier = http://medicines.org.uk/product#511; type = Medicinal Product; domain = Human use; status = Active; statusDate = 2020-08-03 15:11:41+0000; combinedPharmaceuticalDoseForm = Tablet and powder for oral solution; classification = methotrexate</a></p><p><b>role</b>: <span title=\"Codes:{http://hl7.org/fhir/ingredient-role 100000072072}\">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://who-umc.org/idmp/gsid GSID23G92UMX93H45}\">Methotrexate sodium</span></td></tr></table><h3>Strengths</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Presentation[x]</b></td><td><b>TextPresentation</b></td></tr><tr><td style=\"display: none\">*</td><td>2.5 milligram<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM codemg = 'mg')</span>/1 IU<span style=\"background: LightGoldenRodYellow\"> (Details: Strength units applicable in the IDMP PhPID service codeIU = 'arbitrary international unit')</span></td><td>2.5 mg</td></tr></table></blockquote></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Organization #dti</b></p><a name=\"UK-emc-00001/dti\"> </a><a name=\"hcUK-emc-00001/dti\"> </a><a name=\"UK-emc-00001/dti-en-US\"> </a><p><b>active</b>: true</p><p><b>type</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/organization-type bus}\">Datapharm Test FCAT35</span></p><p><b>name</b>: Datapharm Test Inc</p></blockquote></div>"
},
"contained" : [
{
"resourceType" : "MedicinalProductDefinition",
"id" : "5d02cfc1-053f-4694-9ce8-d0ee6c658b72",
"meta" : {
"profile" : [
🔗 "http://who-umc.org/idmp/StructureDefinition/MedicinalProductDefinition-who-php-req"
]
},
"identifier" : [
{
"system" : "http://medicines.org.uk/product",
"value" : "511"
}
],
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-type",
"code" : "MedicinalProduct"
}
]
},
"domain" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-domain",
"code" : "Human"
}
],
"text" : "Human use"
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active"
}
],
"text" : "Active"
},
"statusDate" : "2020-08-03T15:11:41Z",
"combinedPharmaceuticalDoseForm" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/combined-dose-form",
"code" : "100000074064",
"display" : "Tablet and powder for oral solution"
}
],
"text" : "Tablet and powder for oral solution"
},
"classification" : [
{
"coding" : [
{
"system" : "http://www.whocc.no/atc",
"code" : "L04AX03"
}
]
}
],
"attachedDocument" : [
{
"display" : "SPC/511"
}
],
"contact" : [
{
"contact" : {
"reference" : "#dti"
}
}
],
"name" : [
{
"productName" : "Methotrexate 2.5 mg Tablets",
"type" : {
"coding" : [
{
"code" : "RegulatorApprovedName"
}
]
},
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "GBR"
}
]
},
"jurisdiction" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "GBR"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "en"
}
]
}
}
]
}
]
},
{
"resourceType" : "Ingredient",
"id" : "54c6c580-5b34-4032-9403-c9d2154ac073",
"meta" : {
"profile" : [
🔗 "http://who-umc.org/idmp/StructureDefinition/Ingredient-who-php"
]
},
"status" : "active",
"for" : [
{
"reference" : "#5d02cfc1-053f-4694-9ce8-d0ee6c658b72"
}
],
"role" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/ingredient-role",
"code" : "100000072072"
}
],
"text" : "Active"
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "http://who-umc.org/idmp/gsid",
"code" : "GSID23G92UMX93H45"
}
],
"text" : "Methotrexate sodium"
}
},
"strength" : [
{
"presentationRatio" : {
"numerator" : {
"value" : 2.5,
"unit" : "milligram",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 1,
"unit" : "IU",
"system" : "http://who-umc.org/idmp/CodeSystem/strengthUnit",
"code" : "IU"
}
},
"textPresentation" : "2.5 mg"
}
]
}
},
{
"resourceType" : "Organization",
"id" : "dti",
"active" : true,
"type" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/organization-type",
"code" : "bus"
}
],
"text" : "Datapharm Test FCAT35"
}
],
"name" : "Datapharm Test Inc"
}
],
"status" : "draft",
"intent" : "proposal",
"priority" : "routine",
"authoredOn" : "2024-01-17",
"lastModified" : "2024-01-17",
"input" : [
{
"type" : {
"coding" : [
{
"system" : "http://who-umc.org/idmp/CodeSystem/task-input-type",
"code" : "mpd-request-resource",
"display" : "Medicinal Product for PhPID request"
}
],
"text" : "Medicinal Product for PhPID request"
},
"valueReference" : {
"reference" : "#5d02cfc1-053f-4694-9ce8-d0ee6c658b72"
}
},
{
"type" : {
"coding" : [
{
"system" : "http://who-umc.org/idmp/CodeSystem/task-input-type",
"code" : "ingredient-request-resource",
"display" : "Ingredient for PhPID request"
}
],
"text" : "Ingredient for PhPID request"
},
"valueReference" : {
"reference" : "#54c6c580-5b34-4032-9403-c9d2154ac073"
}
},
{
"type" : {
"coding" : [
{
"system" : "http://who-umc.org/idmp/CodeSystem/task-input-type",
"code" : "organization-request-resource",
"display" : "Marketing Auth Holder for PhPID request"
}
],
"text" : "Test by Datapharm for PhPID request"
},
"valueReference" : {
"reference" : "#dti"
}
}
]
}
IG © 2024+ Uppsala Monitoring Centre. Package idmp.who-umc.org.fhir#0.1.0 based on FHIR 5.0.0. Generated 2024-11-11
